Cold Chain: How Peptides Should Be Shipped and Received
The cold chain keeps temperature-sensitive peptides within a controlled range from lab to bench — how they should be shipped, received and stored.
Research peptides are valued for their consistency, and much of that consistency depends on how they are handled between the lab that produces them and the bench where they are used. The phrase "cold chain" describes the effort to keep temperature-sensitive material within a controlled range at every step of that journey.
Why temperature matters
Peptides are more stable as a dry, lyophilised solid than in solution, but they are not indifferent to their environment. Prolonged heat can accelerate degradation even in powdered form, while repeated temperature swings add cumulative stress. Keeping material cool and stable helps protect the integrity of the molecule from packing through to delivery.
How peptides are shipped
Well-packaged shipments often travel with insulated materials or cold packs to buffer against warm transit conditions, and lyophilised peptides tolerate short periods at ambient temperature better than reconstituted ones. This is one practical advantage of the freeze-dried format: it provides a margin of safety during the unavoidable variability of transport.
Receiving and storing a shipment
On arrival, good practice is to inspect the vial promptly, confirm the contents against the accompanying certificate of analysis, and move the material into appropriate cold storage without unnecessary delay. Lyophilised powder is generally kept cold and dry until needed; once reconstituted with bacteriostatic water, the solution is refrigerated, protected from light, and its date of reconstitution recorded. Our reconstitution guide covers those later steps in more detail.
Keep reading
More from the
research bench.
Retatrutide: the triple agonist explained
One molecule, three receptor pathways. Why retatrutide is one of the most closely watched compounds in modern metabolic research.
Tirzepatide: the dual GIP/GLP-1 agonist
How engaging two incretin pathways at once set tirzepatide apart, and what researchers study it for.
Why modified peptides last longer: half-life and modifications
How amino-acid substitutions, fatty-acid chains and added size extend a peptide's half-life, and why it matters in research.
